174 related articles for article (PubMed ID: 19966863)
1. Rapamycin inhibits oncogenic intestinal ion channels and neoplasia in APC(Min/+) mice.
Koehl GE; Spitzner M; Ousingsawat J; Schreiber R; Geissler EK; Kunzelmann K
Oncogene; 2010 Mar; 29(10):1553-60. PubMed ID: 19966863
[TBL] [Abstract][Full Text] [Related]
2. Role of nucleotide excision repair deficiency in intestinal tumorigenesis in multiple intestinal neoplasia (Min) mice.
Steffensen IL; Schut HA; Nesland JM; Tanaka K; Alexander J
Mutat Res; 2006 Dec; 611(1-2):71-82. PubMed ID: 16962818
[TBL] [Abstract][Full Text] [Related]
3. The threshold level of adenomatous polyposis coli protein for mouse intestinal tumorigenesis.
Li Q; Ishikawa TO; Oshima M; Taketo MM
Cancer Res; 2005 Oct; 65(19):8622-7. PubMed ID: 16204028
[TBL] [Abstract][Full Text] [Related]
4. Liposome-mediated adenomatous polyposis coli gene therapy: a novel anti-adenoma strategy in multiple intestinal neoplasia mouse model.
Lee J; Hargest R; Wasan H; Phillips RK
Dis Colon Rectum; 2004 Dec; 47(12):2105-13. PubMed ID: 15657662
[TBL] [Abstract][Full Text] [Related]
5. Morphological and molecular processes of polyp formation in Apc(delta716) knockout mice.
Oshima H; Oshima M; Kobayashi M; Tsutsumi M; Taketo MM
Cancer Res; 1997 May; 57(9):1644-9. PubMed ID: 9135000
[TBL] [Abstract][Full Text] [Related]
6. Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor.
Lal G; Ash C; Hay K; Redston M; Kwong E; Hancock B; Mak T; Kargman S; Evans JF; Gallinger S
Cancer Res; 2001 Aug; 61(16):6131-6. PubMed ID: 11507063
[TBL] [Abstract][Full Text] [Related]
7. Dietary-induced ERbeta upregulation counteracts intestinal neoplasia development in intact male ApcMin/+ mice.
Barone M; Tanzi S; Lofano K; Scavo MP; Pricci M; Demarinis L; Papagni S; Guido R; Maiorano E; Ingravallo G; Comelli MC; Francavilla A; Di Leo A
Carcinogenesis; 2010 Feb; 31(2):269-74. PubMed ID: 19945967
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of colonic ion channels in APC ( Min/+ ) mice.
Ousingsawat J; Spitzner M; Schreiber R; Kunzelmann K
Pflugers Arch; 2008 Aug; 456(5):847-55. PubMed ID: 18247045
[TBL] [Abstract][Full Text] [Related]
9. Synergism between K-rasVal12 and mutant Apc accelerates murine large intestinal tumourigenesis.
Luo F; Poulogiannis G; Ye H; Hamoudi R; Arends MJ
Oncol Rep; 2011 Jul; 26(1):125-33. PubMed ID: 21573497
[TBL] [Abstract][Full Text] [Related]
10. Evidence against dominant negative mechanisms of intestinal polyp formation by Apc gene mutations.
Oshima M; Oshima H; Kobayashi M; Tsutsumi M; Taketo MM
Cancer Res; 1995 Jul; 55(13):2719-22. PubMed ID: 7796392
[TBL] [Abstract][Full Text] [Related]
11. Action of Min and Mom1 on neoplasia in ectopic intestinal grafts.
Gould KA; Dove WF
Cell Growth Differ; 1996 Oct; 7(10):1361-8. PubMed ID: 8891340
[TBL] [Abstract][Full Text] [Related]
12. Chemopreventive effects of dietary folate on intestinal polyps in Apc+/-Msh2-/- mice.
Song J; Sohn KJ; Medline A; Ash C; Gallinger S; Kim YI
Cancer Res; 2000 Jun; 60(12):3191-9. PubMed ID: 10866310
[TBL] [Abstract][Full Text] [Related]
13. Suppression of intestinal polyposis in Apcmin/+ mice by targeting the nitric oxide or poly(ADP-ribose) pathways.
Mabley JG; Pacher P; Bai P; Wallace R; Goonesekera S; Virag L; Southan GJ; Szabó C
Mutat Res; 2004 Apr; 548(1-2):107-16. PubMed ID: 15063141
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of mammalian target of rapamycin reverses alveolar epithelial neoplasia induced by oncogenic K-ras.
Wislez M; Spencer ML; Izzo JG; Juroske DM; Balhara K; Cody DD; Price RE; Hittelman WN; Wistuba II; Kurie JM
Cancer Res; 2005 Apr; 65(8):3226-35. PubMed ID: 15833854
[TBL] [Abstract][Full Text] [Related]
15. Reciprocal expression of ERalpha and ERbeta is associated with estrogen-mediated modulation of intestinal tumorigenesis.
Weyant MJ; Carothers AM; Mahmoud NN; Bradlow HL; Remotti H; Bilinski RT; Bertagnolli MM
Cancer Res; 2001 Mar; 61(6):2547-51. PubMed ID: 11289129
[TBL] [Abstract][Full Text] [Related]
16. Adiposity-related protection of intestinal tumorigenesis: interaction with dietary calcium.
Ding S; McEntee MF; Whelan J; Zemel M
Nutr Cancer; 2007; 58(2):153-61. PubMed ID: 17640161
[TBL] [Abstract][Full Text] [Related]
17. Plasminogen activator inhibitor-1 (Pai-1) blockers suppress intestinal polyp formation in Min mice.
Mutoh M; Niho N; Komiya M; Takahashi M; Ohtsubo R; Nakatogawa K; Ueda K; Sugimura T; Wakabayashi K
Carcinogenesis; 2008 Apr; 29(4):824-9. PubMed ID: 18258607
[TBL] [Abstract][Full Text] [Related]
18. Naringin, a natural dietary compound, prevents intestinal tumorigenesis in Apc (Min/+) mouse model.
Zhang YS; Li Y; Wang Y; Sun SY; Jiang T; Li C; Cui SX; Qu XJ
J Cancer Res Clin Oncol; 2016 May; 142(5):913-25. PubMed ID: 26702935
[TBL] [Abstract][Full Text] [Related]
19. Deletion of the WNT target and cancer stem cell marker CD44 in Apc(Min/+) mice attenuates intestinal tumorigenesis.
Zeilstra J; Joosten SP; Dokter M; Verwiel E; Spaargaren M; Pals ST
Cancer Res; 2008 May; 68(10):3655-61. PubMed ID: 18483247
[TBL] [Abstract][Full Text] [Related]
20. Elevated Dnmt3a activity promotes polyposis in Apc(Min) mice by relaxing extracellular restraints on Wnt signaling.
Samuel MS; Suzuki H; Buchert M; Putoczki TL; Tebbutt NC; Lundgren-May T; Christou A; Inglese M; Toyota M; Heath JK; Ward RL; Waring PM; Ernst M
Gastroenterology; 2009 Sep; 137(3):902-13, 913.e1-11. PubMed ID: 19454286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]